Drug repurposing breakthrough: varespladib curbs snakebite-induced necrosis

FHS
May 10, 2024
3:23 am

Researchers discovered that venom toxins from African spitting cobras cause severe dermonecrosis, highlighting the need for targeted treatments like the repurposed drug varespladib.

Biden’s Doc Says No Parkinson’s; Overlooked COVID Symptom; STDs Spiked Among Seniors

Note that some links may require registration or subscription. President Joe Biden has not seen a neurologist outside of his annual physical and his last

July 10, 2024

Biogen makes its move, announcing a $7.3B deal for Reata

Biogen and its new CEO are finally wading into 2023’s M&A wave with a $7.3 billion deal for Reata Pharmaceuticals, which just secured FDA approval

July 29, 2023

Bristol buys out cancer cell therapy partner

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, let’s get

March 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.